TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 394 filers reported holding TANDEM DIABETES CARE INC in Q4 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $419,139 | -15.4% | 20,180 | 0.0% | 0.09% | -8.5% |
| Q2 2023 | $495,217 | -36.7% | 20,180 | +4.7% | 0.09% | -37.3% |
| Q1 2023 | $782,352 | -3.4% | 19,265 | +6.9% | 0.15% | -9.6% |
| Q4 2022 | $810,224 | -6.0% | 18,025 | 0.0% | 0.17% | -14.4% |
| Q3 2022 | $862,000 | -9.3% | 18,025 | +12.3% | 0.19% | +3.2% |
| Q2 2022 | $950,000 | -49.1% | 16,045 | 0.0% | 0.19% | -38.2% |
| Q1 2022 | $1,866,000 | -5.3% | 16,045 | +22.6% | 0.30% | +0.7% |
| Q4 2021 | $1,970,000 | +26.0% | 13,090 | 0.0% | 0.30% | +26.9% |
| Q3 2021 | $1,563,000 | +22.6% | 13,090 | 0.0% | 0.24% | +22.1% |
| Q2 2021 | $1,275,000 | +5.2% | 13,090 | -4.7% | 0.20% | -8.5% |
| Q1 2021 | $1,212,000 | +61.4% | 13,739 | +75.0% | 0.21% | +22.4% |
| Q4 2020 | $751,000 | +0.9% | 7,851 | +19.8% | 0.17% | -22.0% |
| Q3 2020 | $744,000 | +39.3% | 6,554 | +21.3% | 0.22% | +23.9% |
| Q2 2020 | $534,000 | – | 5,403 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 474,929 | $22,725,000 | 3.92% |
| Soleus Capital Management, L.P. | 415,200 | $19,867,000 | 2.70% |
| First Light Asset Management, LLC | 485,620 | $23,237,000 | 2.35% |
| Eagle Health Investments LP | 196,400 | $9,398,000 | 2.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 218,049 | $10,434,000 | 1.66% |
| EMINENCE CAPITAL, LP | 1,590,787 | $76,119,000 | 1.59% |
| Brown Capital Management | 2,010,230 | $96,190,000 | 1.35% |
| Chicago Capital, LLC | 479,873 | $22,962,000 | 1.33% |
| Intrinsic Edge Capital Management LLC | 247,391 | $11,838,000 | 1.29% |
| Bellevue Group AG | 1,566,015 | $74,933,000 | 1.08% |